Dietary vitamin D intake, 25-hydroxyvitamin D3 levels and premenstrual syndrome in a college-aged population.
Bertone-Johnson ER1, Chocano-Bedoya PO, Zagarins SE, Micka AE, Ronnenberg AG.
1Division of Biostatistics and Epidemiology, Department of Public Health, University of Massachusetts, Amherst, MA 01003-9304, USA. ebertone@schoolph.umass.edu
Abstract
High
dietary intake of vitamin D may reduce the risk of premenstrual
syndrome (PMS), perhaps by affecting calcium levels, cyclic sex steroid
hormone fluctuations, and/or neurotransmitter function. Only a small
number of previous studies have evaluated this relationship and none
have focused on young women. We assessed this relationship in a
cross-sectional analysis within the UMass Vitamin D Status Study.
Between 2006 and 2008, 186 women aged 18-30 (mean age=21.6 years)
completed a validated food frequency questionnaire, additional
questionnaires to assess menstrual symptoms and other health and
lifestyle factors, and provided a fasting blood sample collected during
the late luteal phase of their menstrual cycle. Among all study
participants, results suggested the possibility of an inverse
association between intake of vitamin D from food sources and overall
menstrual symptom severity, though were not statistically significant;
mean intakes in women reporting menstrual symptom severity of
none/minimal, mild, and moderate/severe were 253, 214, and 194 IU/day,
respectively (P=0.18). From among all study participants, 44 women
meeting standard criteria for PMS and 46 women meeting control criteria
were included in additional case-control analyses. In these women, after
adjustment for age, body mass index, smoking status and total calcium
intake, higher intake of vitamin D from foods was associated with a
significant lower prevalence of PMS. Women reporting vitamin D intake
from food sources of >or=100 IU/day had a prevalence odds ratio of
0.31 compared to those reporting<100 IU/day (95% confidence
interval=0.10-0.98). Late luteal phase 25-hydroxyvitamin D3 levels were
not associated with prevalent PMS. Results from this pilot study suggest
that a relationship between vitamin D and PMS is possible, though
larger studies are needed to further evaluate this relationship and to
investigate whether 25-hydroxyvitamin D3 levels in the follicular or
early luteal phases of the menstrual cycle may be related to PMS risk.
Copyright (c) 2010 Elsevier Ltd. All rights reserved.
J Steroid Biochem Mol Biol. 2010 Jul;121(1-2):434-7. doi: 10.1016/j.jsbmb.2010.03.076. Epub 2010 Apr 14.
http://www.sciencedirect.com/science/article/pii/S0960076010001755
Md. PhD. Patricia Chocano. Ex miembro del GII.